Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Janssen Sciences Ireland Uc patents


Recent patent applications related to Janssen Sciences Ireland Uc. Janssen Sciences Ireland Uc is listed as an Agent/Assignee. Note: Janssen Sciences Ireland Uc may have other listings under different names/spellings. We're not affiliated with Janssen Sciences Ireland Uc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "J" | Janssen Sciences Ireland Uc-related inventors


Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones

. . . . . . . . . . The present invention is related to novel compounds of formula (i) that inhibit the activity of the fabi enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.. ... Janssen Sciences Ireland Uc

Hydrobromide salt of an anti-hiv compound

. . . . Solid dispersions and dosage forms comprising the hydrobromide salt of a diarylpyrimidine derivative, useful as an anti-hiv agent.. . ... Janssen Sciences Ireland Uc

Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)

. . . . . . The invention concerns novel substituted tricyclic pyrazolo pyrimidine compounds of formula (i-a) or (i-b) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use sin the treatment of respiratory syncytial virus infection.. ... Janssen Sciences Ireland Uc

Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)

The invention concerns novel substituted bicyclic pyrazolo pyrimidine compounds of formula (i) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.. ... Janssen Sciences Ireland Uc

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

This invention relates to heterocyclic substituted 2-amino-quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.. . ... Janssen Sciences Ireland Uc

2-aminopyrimidine derivatives for the treatment of viral infections

This invention relates to 2-aminopyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.. . ... Janssen Sciences Ireland Uc

Combinations and methods comprising a capsid assembly inhibitor

The present disclosure is directed to capsid assembly inhibitor compositions and methods for use in the treatment of hepatitis b virus infection.. . ... Janssen Sciences Ireland Uc

Substituted pyridine-piperazinyl analogues as rsv antiviral compounds

The invention concerns novel substituted pyridine-piperazinyl analogues of formula (i) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.. ... Janssen Sciences Ireland Uc

Purine derivatives for the treatment of viral infections

The present invention relates to purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.. . ... Janssen Sciences Ireland Uc

Pteridines useful as hcv inhibitors and methods for the preparation thereof

The present invention relates to the use of pteridines as inhibitors of hcv replication as well as their use in pharmaceutical compositions aimed to treat or combat hcv infections. In addition, the present invention relates to compounds per se and their use as medicines. ... Janssen Sciences Ireland Uc

Pseudopolymorphic forms of a hiv protease inhibitor

. . New pseudopolymorphic forms of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.. . ... Janssen Sciences Ireland Uc

Pyrrolopyrimidines for use in influenza virus infection

The invention relates to compounds having the structure of formula (i) which can be used for the treatment of or against influenza infections.. . ... Janssen Sciences Ireland Uc

Pyrimidine derivatives for the treatment of viral infections

This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as hcv or hbv.. . ... Janssen Sciences Ireland Uc

Compacted solid dosage form

The present invention relates to dosage forms comprising a compressed blend of a biologically active ingredient, one or more polymers like a poly(a-hydroxy carboxylic acid) in which optionally is incorporated a glass transition modifying agent, and optional further ingredients, wherein the polymer or polymeric mixture has a specific glass transition temperature which causes the system to be in the glassy state at ambient conditions before administration and to be in the rubbery state under the physiological conditions to which the system is exposed after administration, resulting in pulsed release of said biologically active ingredient.. . ... Janssen Sciences Ireland Uc

08/10/17 / #20170226102

Indoles for use in influenza virus infection

The invention relates to compounds having the structure of formula (i) which can be used for the treatment of or against influenza infections.. . ... Janssen Sciences Ireland Uc

06/22/17 / #20170174683

Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones

The present invention is related to novel compounds of formula (i) that inhibit the activity of the fabi enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.. ... Janssen Sciences Ireland Uc

06/15/17 / #20170165287

Crystal form of a nucleoside inhibitor of hcv

Provided are crystalline forms of the compound of formula (i), which is a nucleoside inhibitor of hcv, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.. . ... Janssen Sciences Ireland Uc

04/13/17 / #20170100399

Microbicidal pyrimidine or triazine containing compounds

. . The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being with hiv, in particular, the present compounds prevent sexual hiv transmission in humans,. ... Janssen Sciences Ireland Uc

04/13/17 / #20170100398

Combinations of a pyrimidine containing nnrti with rt inhibitors

The present invention concerns combinations of a pyrimidine containing nnrti with nucleoside reverse transcriptase inhibitors and nucleotide reverse transcriptase inhibitors useful for the treatment of hiv infected patients or for the prevention of hiv transmission or infection.. . ... Janssen Sciences Ireland Uc

02/16/17 / #20170044218

Use of a hiv derived accessory protein for the reactivation of latent hiv

The present invention concerns the use of a protein comprising at least a hiv-derived accessory protein tat (trans-activator of transcription) or any derivative thereof for the reactivation of latent human immunodeficiency virus (hiv) from cells present in a hiv-infected patient.. . ... Janssen Sciences Ireland Uc

02/16/17 / #20170044172

Spiro urea compounds as rsv antiviral compounds

The invention concerns novel substituted spiro urea azetidinyl or piperidinyl compounds of formula (i) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.. ... Janssen Sciences Ireland Uc

02/16/17 / #20170044169

Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases

This invention concerns pyrrolo[3,2-d]pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treatment and/or therapy of diseases.. . ... Janssen Sciences Ireland Uc

02/02/17 / #20170027967

Pharmaceutical formulations

. . The invention provides a solid oral dosage form comprising rilpivirine or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.. . ... Janssen Sciences Ireland Uc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Janssen Sciences Ireland Uc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Janssen Sciences Ireland Uc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###